Biodefense Market Report

Global Biodefense Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 10, 2022
  • PAGES：235
  • REPORT CODE：GMM807860
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Biodefense market report explains the definition, types, applications, major countries, and major players of the Biodefense market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • SIGA Technologies

    • Ichor Medical Systems

    • Alnylam Pharmaceuticals

    • Elusys Therapeutics

    • DynPort Vaccine Company

    • Cleveland BioLabs

    • Altimmune

    • Achaogen

    • Bavarian Nordic

    • Emergent BioSolutions

    By Type:

    • Anthrax

    • Smallpox

    • Botulism

    • Radiation/Nuclear

    • Others

    By End-User:

    • Military Market

    • Civilian Market

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Biodefense Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Biodefense Outlook to 2028- Original Forecasts

    • 2.2 Biodefense Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Biodefense Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Biodefense Market- Recent Developments

    • 6.1 Biodefense Market News and Developments

    • 6.2 Biodefense Market Deals Landscape

    7 Biodefense Raw Materials and Cost Structure Analysis

    • 7.1 Biodefense Key Raw Materials

    • 7.2 Biodefense Price Trend of Key Raw Materials

    • 7.3 Biodefense Key Suppliers of Raw Materials

    • 7.4 Biodefense Market Concentration Rate of Raw Materials

    • 7.5 Biodefense Cost Structure Analysis

      • 7.5.1 Biodefense Raw Materials Analysis

      • 7.5.2 Biodefense Labor Cost Analysis

      • 7.5.3 Biodefense Manufacturing Expenses Analysis

    8 Global Biodefense Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Biodefense Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Biodefense Export by Region (Top 10 Countries) (2017-2028)

    9 Global Biodefense Market Outlook by Types and Applications to 2022

    • 9.1 Global Biodefense Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Anthrax Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Smallpox Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Botulism Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Radiation/Nuclear Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Biodefense Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Military Market Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Civilian Market Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Biodefense Market Analysis and Outlook till 2022

    • 10.1 Global Biodefense Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Biodefense Consumption (2017-2022)

      • 10.2.2 Canada Biodefense Consumption (2017-2022)

      • 10.2.3 Mexico Biodefense Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Biodefense Consumption (2017-2022)

      • 10.3.2 UK Biodefense Consumption (2017-2022)

      • 10.3.3 Spain Biodefense Consumption (2017-2022)

      • 10.3.4 Belgium Biodefense Consumption (2017-2022)

      • 10.3.5 France Biodefense Consumption (2017-2022)

      • 10.3.6 Italy Biodefense Consumption (2017-2022)

      • 10.3.7 Denmark Biodefense Consumption (2017-2022)

      • 10.3.8 Finland Biodefense Consumption (2017-2022)

      • 10.3.9 Norway Biodefense Consumption (2017-2022)

      • 10.3.10 Sweden Biodefense Consumption (2017-2022)

      • 10.3.11 Poland Biodefense Consumption (2017-2022)

      • 10.3.12 Russia Biodefense Consumption (2017-2022)

      • 10.3.13 Turkey Biodefense Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Biodefense Consumption (2017-2022)

      • 10.4.2 Japan Biodefense Consumption (2017-2022)

      • 10.4.3 India Biodefense Consumption (2017-2022)

      • 10.4.4 South Korea Biodefense Consumption (2017-2022)

      • 10.4.5 Pakistan Biodefense Consumption (2017-2022)

      • 10.4.6 Bangladesh Biodefense Consumption (2017-2022)

      • 10.4.7 Indonesia Biodefense Consumption (2017-2022)

      • 10.4.8 Thailand Biodefense Consumption (2017-2022)

      • 10.4.9 Singapore Biodefense Consumption (2017-2022)

      • 10.4.10 Malaysia Biodefense Consumption (2017-2022)

      • 10.4.11 Philippines Biodefense Consumption (2017-2022)

      • 10.4.12 Vietnam Biodefense Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Biodefense Consumption (2017-2022)

      • 10.5.2 Colombia Biodefense Consumption (2017-2022)

      • 10.5.3 Chile Biodefense Consumption (2017-2022)

      • 10.5.4 Argentina Biodefense Consumption (2017-2022)

      • 10.5.5 Venezuela Biodefense Consumption (2017-2022)

      • 10.5.6 Peru Biodefense Consumption (2017-2022)

      • 10.5.7 Puerto Rico Biodefense Consumption (2017-2022)

      • 10.5.8 Ecuador Biodefense Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Biodefense Consumption (2017-2022)

      • 10.6.2 Kuwait Biodefense Consumption (2017-2022)

      • 10.6.3 Oman Biodefense Consumption (2017-2022)

      • 10.6.4 Qatar Biodefense Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Biodefense Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Biodefense Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Biodefense Consumption (2017-2022)

      • 10.7.2 South Africa Biodefense Consumption (2017-2022)

      • 10.7.3 Egypt Biodefense Consumption (2017-2022)

      • 10.7.4 Algeria Biodefense Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Biodefense Consumption (2017-2022)

      • 10.8.2 New Zealand Biodefense Consumption (2017-2022)

    11 Global Biodefense Competitive Analysis

    • 11.1 SIGA Technologies

      • 11.1.1 SIGA Technologies Company Details

      • 11.1.2 SIGA Technologies Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 SIGA Technologies Biodefense Main Business and Markets Served

      • 11.1.4 SIGA Technologies Biodefense Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Ichor Medical Systems

      • 11.2.1 Ichor Medical Systems Company Details

      • 11.2.2 Ichor Medical Systems Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Ichor Medical Systems Biodefense Main Business and Markets Served

      • 11.2.4 Ichor Medical Systems Biodefense Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Alnylam Pharmaceuticals

      • 11.3.1 Alnylam Pharmaceuticals Company Details

      • 11.3.2 Alnylam Pharmaceuticals Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Alnylam Pharmaceuticals Biodefense Main Business and Markets Served

      • 11.3.4 Alnylam Pharmaceuticals Biodefense Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Elusys Therapeutics

      • 11.4.1 Elusys Therapeutics Company Details

      • 11.4.2 Elusys Therapeutics Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Elusys Therapeutics Biodefense Main Business and Markets Served

      • 11.4.4 Elusys Therapeutics Biodefense Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 DynPort Vaccine Company

      • 11.5.1 DynPort Vaccine Company Company Details

      • 11.5.2 DynPort Vaccine Company Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 DynPort Vaccine Company Biodefense Main Business and Markets Served

      • 11.5.4 DynPort Vaccine Company Biodefense Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Cleveland BioLabs

      • 11.6.1 Cleveland BioLabs Company Details

      • 11.6.2 Cleveland BioLabs Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Cleveland BioLabs Biodefense Main Business and Markets Served

      • 11.6.4 Cleveland BioLabs Biodefense Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Altimmune

      • 11.7.1 Altimmune Company Details

      • 11.7.2 Altimmune Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Altimmune Biodefense Main Business and Markets Served

      • 11.7.4 Altimmune Biodefense Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Achaogen

      • 11.8.1 Achaogen Company Details

      • 11.8.2 Achaogen Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Achaogen Biodefense Main Business and Markets Served

      • 11.8.4 Achaogen Biodefense Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Bavarian Nordic

      • 11.9.1 Bavarian Nordic Company Details

      • 11.9.2 Bavarian Nordic Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Bavarian Nordic Biodefense Main Business and Markets Served

      • 11.9.4 Bavarian Nordic Biodefense Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Emergent BioSolutions

      • 11.10.1 Emergent BioSolutions Company Details

      • 11.10.2 Emergent BioSolutions Biodefense Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Emergent BioSolutions Biodefense Main Business and Markets Served

      • 11.10.4 Emergent BioSolutions Biodefense Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Biodefense Market Outlook by Types and Applications to 2028

    • 12.1 Global Biodefense Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Anthrax Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Smallpox Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Botulism Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Radiation/Nuclear Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Biodefense Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Military Market Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Civilian Market Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Biodefense Market Analysis and Outlook to 2028

    • 13.1 Global Biodefense Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Biodefense Consumption Forecast (2022-2028)

      • 13.2.2 Canada Biodefense Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Biodefense Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Biodefense Consumption Forecast (2022-2028)

      • 13.3.2 UK Biodefense Consumption Forecast (2022-2028)

      • 13.3.3 Spain Biodefense Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Biodefense Consumption Forecast (2022-2028)

      • 13.3.5 France Biodefense Consumption Forecast (2022-2028)

      • 13.3.6 Italy Biodefense Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Biodefense Consumption Forecast (2022-2028)

      • 13.3.8 Finland Biodefense Consumption Forecast (2022-2028)

      • 13.3.9 Norway Biodefense Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Biodefense Consumption Forecast (2022-2028)

      • 13.3.11 Poland Biodefense Consumption Forecast (2022-2028)

      • 13.3.12 Russia Biodefense Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Biodefense Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Biodefense Consumption Forecast (2022-2028)

      • 13.4.2 Japan Biodefense Consumption Forecast (2022-2028)

      • 13.4.3 India Biodefense Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Biodefense Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Biodefense Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Biodefense Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Biodefense Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Biodefense Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Biodefense Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Biodefense Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Biodefense Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Biodefense Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Biodefense Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Biodefense Consumption Forecast (2022-2028)

      • 13.5.3 Chile Biodefense Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Biodefense Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Biodefense Consumption Forecast (2022-2028)

      • 13.5.6 Peru Biodefense Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Biodefense Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Biodefense Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Biodefense Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Biodefense Consumption Forecast (2022-2028)

      • 13.6.3 Oman Biodefense Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Biodefense Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Biodefense Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Biodefense Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Biodefense Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Biodefense Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Biodefense Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Biodefense Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Biodefense Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Biodefense Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Biodefense

    • Figure of Biodefense Picture

    • Table Global Biodefense Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Biodefense Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Anthrax Consumption and Growth Rate (2017-2022)

    • Figure Global Smallpox Consumption and Growth Rate (2017-2022)

    • Figure Global Botulism Consumption and Growth Rate (2017-2022)

    • Figure Global Radiation/Nuclear Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Military Market Consumption and Growth Rate (2017-2022)

    • Figure Global Civilian Market Consumption and Growth Rate (2017-2022)

    • Figure Global Biodefense Consumption by Country (2017-2022)

    • Table North America Biodefense Consumption by Country (2017-2022)

    • Figure United States Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Canada Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Mexico Biodefense Consumption and Growth Rate (2017-2022)

    • Table Europe Biodefense Consumption by Country (2017-2022)

    • Figure Germany Biodefense Consumption and Growth Rate (2017-2022)

    • Figure UK Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Spain Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Belgium Biodefense Consumption and Growth Rate (2017-2022)

    • Figure France Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Italy Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Denmark Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Finland Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Norway Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Sweden Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Poland Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Russia Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Turkey Biodefense Consumption and Growth Rate (2017-2022)

    • Table APAC Biodefense Consumption by Country (2017-2022)

    • Figure China Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Japan Biodefense Consumption and Growth Rate (2017-2022)

    • Figure India Biodefense Consumption and Growth Rate (2017-2022)

    • Figure South Korea Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Thailand Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Singapore Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Philippines Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Biodefense Consumption and Growth Rate (2017-2022)

    • Table South America Biodefense Consumption by Country (2017-2022)

    • Figure Brazil Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Colombia Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Chile Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Argentina Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Peru Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Biodefense Consumption and Growth Rate (2017-2022)

    • Table GCC Biodefense Consumption by Country (2017-2022)

    • Figure Bahrain Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Oman Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Qatar Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Biodefense Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Biodefense Consumption and Growth Rate (2017-2022)

    • Table Africa Biodefense Consumption by Country (2017-2022)

    • Figure Nigeria Biodefense Consumption and Growth Rate (2017-2022)

    • Figure South Africa Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Egypt Biodefense Consumption and Growth Rate (2017-2022)

    • Figure Algeria Biodefense Consumption and Growth Rate (2017-2022)

    • Table Oceania Biodefense Consumption by Country (2017-2022)

    • Figure Australia Biodefense Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Biodefense Consumption and Growth Rate (2017-2022)

    • Table SIGA Technologies Company Details

    • Table SIGA Technologies Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table SIGA Technologies Biodefense Main Business and Markets Served

    • Table SIGA Technologies Biodefense Product Portfolio

    • Table Ichor Medical Systems Company Details

    • Table Ichor Medical Systems Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ichor Medical Systems Biodefense Main Business and Markets Served

    • Table Ichor Medical Systems Biodefense Product Portfolio

    • Table Alnylam Pharmaceuticals Company Details

    • Table Alnylam Pharmaceuticals Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alnylam Pharmaceuticals Biodefense Main Business and Markets Served

    • Table Alnylam Pharmaceuticals Biodefense Product Portfolio

    • Table Elusys Therapeutics Company Details

    • Table Elusys Therapeutics Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table Elusys Therapeutics Biodefense Main Business and Markets Served

    • Table Elusys Therapeutics Biodefense Product Portfolio

    • Table DynPort Vaccine Company Company Details

    • Table DynPort Vaccine Company Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table DynPort Vaccine Company Biodefense Main Business and Markets Served

    • Table DynPort Vaccine Company Biodefense Product Portfolio

    • Table Cleveland BioLabs Company Details

    • Table Cleveland BioLabs Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cleveland BioLabs Biodefense Main Business and Markets Served

    • Table Cleveland BioLabs Biodefense Product Portfolio

    • Table Altimmune Company Details

    • Table Altimmune Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table Altimmune Biodefense Main Business and Markets Served

    • Table Altimmune Biodefense Product Portfolio

    • Table Achaogen Company Details

    • Table Achaogen Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table Achaogen Biodefense Main Business and Markets Served

    • Table Achaogen Biodefense Product Portfolio

    • Table Bavarian Nordic Company Details

    • Table Bavarian Nordic Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bavarian Nordic Biodefense Main Business and Markets Served

    • Table Bavarian Nordic Biodefense Product Portfolio

    • Table Emergent BioSolutions Company Details

    • Table Emergent BioSolutions Biodefense Sales, Price, Value and Gross Profit (2017-2022)

    • Table Emergent BioSolutions Biodefense Main Business and Markets Served

    • Table Emergent BioSolutions Biodefense Product Portfolio

    • Figure Global Anthrax Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Smallpox Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Botulism Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Radiation/Nuclear Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Military Market Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Civilian Market Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biodefense Consumption Forecast by Country (2022-2028)

    • Table North America Biodefense Consumption Forecast by Country (2022-2028)

    • Figure United States Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Biodefense Consumption Forecast by Country (2022-2028)

    • Figure Germany Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Biodefense Consumption Forecast by Country (2022-2028)

    • Figure China Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Biodefense Consumption Forecast by Country (2022-2028)

    • Figure Brazil Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Biodefense Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Biodefense Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Biodefense Consumption Forecast by Country (2022-2028)

    • Figure Australia Biodefense Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Biodefense Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US